The Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II)

The Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II) is a regional cancer network aimed at reducing prostate, breast and colorectal cancer disparities among adult African Americans in North Carolina. CCN II combines the strengths of the community with resources and research expertise at UNC to reduce cancer disparities through education, research and training.

Based at the University of North Carolina at Chapel Hill, CCN II is comprised of a Research Program, Community Outreach Program, Training Program and Administrative Core.

The Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II) is supported by the National Cancer Institute's Center to Reduce Cancer Health Disparities through its Community Network Program Centers (U54-CA153602)

 
Sisters Network Inc is pleased to announce the 2013 African American Breast Cancer Conference Tour. The Conference Tour will bring expertise and experience to approximately 10 U.S. cities with the assistance of affiliate chapters. The tour will kick off in Houston, TX on January 26, 2013 and conclude in Memphis, TN on October 26, 2013. Sisters Network Triangle will serve as a conference host site on February 23, 2013.



Obese women might be able to eliminate their increased risk for postmenopausal breast cancer by taking measures during perimenopause to prevent weight gain and to therapeutically control the metabolic effects of their obesity, according to the results of a preclinical study in an animal model from the University of Colorado Anschutz Health and Wellness Center, published in Cancer Research, a journal of the American Association for Cancer Research. The University of Colorado is home to the University of Colorado Cancer Center. (More...)

Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators. Finding multiple mutations instead of just one primary mutation that can be targeted for therapy sheds more light on the challenges of treating triple-negative breast cancer. (More...)

A study from the Wayne State University School of Medicine and the Barbara Ann Karmanos Cancer Institute comparing how physicians discuss clinical trials during clinical interactions with black patients versus white patients further confirms racial disparities in the quality of communication between physicians and patients. Oncologists provided black patients with less information overall about cancer clinical trials compared with white patients, according to data presented at the Fifth AACR Conference on The Science of Cancer Health Disparities, Oct. 27-30, 2012. (More...)